BB-86-BE19_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (2s)-1-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}-3-Phenylpropan-2-Amine, Inhibitors of Signal Transduction Pathways;PKB alpha/Akt1 Inhibitors;cAMP-Dependent Protein Kinase (PKA) Inhibitors targeting PRKACA, PRKACB, PRKACG (Novartis, 11314340)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/11314340
Similar Terms
Downloads & Tools

Genes

16 genes differentially expressed following the BB-86-BE19_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RHOG ras homolog family member G 0.491356
LBHD1 LBH domain containing 1 0.340537
MYH6 myosin, heavy chain 6, cardiac muscle, alpha 0.269537
SNRPG small nuclear ribonucleoprotein polypeptide G 0.223288

decreased expression

Symbol Name Standardized Value
SAC3D1 SAC3 domain containing 1 -1.10177
RPS17 ribosomal protein S17 -0.698878
EIF2D eukaryotic translation initiation factor 2D -0.690163
ADAM9 ADAM metallopeptidase domain 9 -0.340537
XTBD1 XRN2 binding domain containing 1 -0.325416
PSEN2 presenilin 2 -0.304476
ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif, 6 -0.278344
SLC1A4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 -0.269537
GPR107 G protein-coupled receptor 107 -0.265276
HEXIM2 hexamethylene bis-acetamide inducible 2 -0.223288
GLI2 GLI family zinc finger 2 -0.222519
PIGC phosphatidylinositol glycan anchor biosynthesis, class C -0.203591